Prestige Consumer Healthcare Inc (PBH) reported better-than-expected financial results for the second quarter of fiscal 2026. The company achieved earnings per share (EPS) of $1.07, surpassing Wall Street's consensus estimate of $0.98 by $0.09. Revenue matched expectations at $0.3 billion.
This update provides insight into Prestige Consumer Healthcare's operational performance and financial health. The firm, based in Tarrytown, New York, specializes in the marketing, sale, and distribution of pharmaceutical drugs and consumer products, employing 600 full-time staff. Its diverse portfolio includes well-known brands such as Monistat, BC, and Clear Eyes, catering to various health and personal care needs.
The company plans to host an earnings conference call at BMO to discuss these results further and offer additional commentary on its business performance. Investors are encouraged to review the full earnings release for a comprehensive understanding of the quarter's results and future outlook.
Looking ahead, Prestige Consumer Healthcare is set to report its next earnings on August 4, 2026, with EPS and revenue estimates of $1.013 and $0.3 billion, respectively.